St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for Stuart M. Essig
73.03
-0.58 (-0.79%)
Jul 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 72.40 - 73.72
52 week 54.80 - 76.33
Open 73.72
Vol / Avg. 1.03M/1.08M
Mkt cap 20.53B
P/E 20.80
Div/yield 0.29/1.59
EPS 3.51
Shares 281.18M
Beta 1.37
Inst. own 86%
Jul 22, 2015
Q2 2015 St. Jude Medical Inc Earnings Release - 9:30AM EDT - Add to calendar
Jul 22, 2015
Q2 2015 St. Jude Medical Inc Earnings Call - 8:00AM EDT - Add to calendar
May 12, 2015
St. Jude Medical Inc at Bank of America Merrill Lynch Health Care Conference
May 7, 2015
St. Jude Medical Inc Annual Shareholders Meeting
Apr 22, 2015
Q1 2015 St. Jude Medical Inc Earnings Release
Apr 22, 2015
Q1 2015 St. Jude Medical Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin 19.03% 16.99%
Operating margin 24.16% 20.47%
EBITD margin - 31.31%
Return on average assets 10.47% 9.34%
Return on average equity 26.13% 23.77%
Employees 16,000 -
CDP Score - -

Address

1 Saint Jude Medical Dr
SAINT PAUL, MN 55117-1789
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 47
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 54
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 51
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 46
Bio & Compensation  - Reuters
Lisa Malden Andrade Chief Marketing Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
I. Paul Bae Chief Marketing Officer, Vice President - Global Human Resources
Age: 50
Bio & Compensation  - Reuters